Entity
Company
Location
6925 Oakland Mills Road, #701, Columbia, MD
Signature
Foundation Fighting Blindness Retinal Degeneration Fund, By: /s/ Lorna A. Knick, Attorney-in-Fact for Russell Kelley
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Foundation Fighting Blindness Retinal Degeneration Fund:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ocuphire Pharma, Inc. Director, Other* Common Stock 2.56M $4.53M $1.77 Oct 22, 2024 Direct

Insider Reports Filed by Foundation Fighting Blindness Retinal Degeneration Fund

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IRD Opus Genetics, Inc. Oct 22, 2024 0 $0 3 Oct 29, 2024 Director, Other*